Evidence map›Paper›PMID 39885002›Full record

ReviewCurrent nutrition reports2025

Critical Review of Ketogenic Diet Throughout the Cancer Continuum for Neuroglioma: Insights from a Medical Nutrition Therapy (MNT) Perspective.

Kristina D Thomopoulos-Titomihelakis, Hillary Sachs, Rayna McCann, Qianhui Zhang, Sydney Kurnit, Genesis Codoni De Juan, Amanda Rushing

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Current nutrition reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Kristina D Thomopoulos-TitomihelakisMemorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. thomopk@mskcc.org.
Hillary SachsHillary Sachs Nutrition, Scotch Plains, NJ, 07076, USA. HillarySachsNutrition@gmail.com.
Rayna McCannKate Farms, 30 S. La Patera Lane, Goleta, CA, 93117, USA.
Qianhui ZhangDepartment of Nutrition and Public Health, Hunter College, City University of New York, 2180 3 Ave, New York, NY, 10035, USA.
Sydney KurnitMemorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Genesis Codoni De JuanMemorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Amanda RushingDepartment of Vascular Surgery, Mount Sinai Hospital, 1468 Madison Ave, New York, NY, 10029, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PURPOSE OF REVIEW: A Ketogenic diet (KD; a diet comprised of 75% fat, 20% protein and 5% carbohydrates) has gained much popularity in recent years, especially regarding neurogliomas (or "gliomas"). This review critically assesses literature on the application of KD throughout the cancer continuum from a Medical Nutrition Therapy (MNT) perspective. RECENT

findings2021 revised classification standards for Central Nervous System (CNS) tumors are available. Despite research on KD and CNS tumors increasing, the role and benefits of MNT to augment side effects of traditional treatment and KD throughout the cancer continuum remain unclear. Glioma cancer survivors may benefit from a KD. It is a challenging, yet feasible non-pharmacological adjuvant approach. More research is needed regarding KD for prevention and post-treatment of glioma. Standard guidelines regarding macronutrient composition of KD for glioma are warranted. The need and benefits of nutritional guidance provided by a Registered Dietitian Nutritionist (RD or RDNs) during adherence to KD are understated.

Indexed as

Brain NeoplasmsDiet, KetogenicGliomaNutrition TherapyHumansCancer survivorshipGliomaIntermittent fastingKetogenic dietMedical nutrition therapyNeuroglioma

Identifiers

PMID39885002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.